MedTrace Logo

Vest Prevention of Early Sudden Death Trial and VEST Registry

NCT01446965 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2348

Last updated 2021-01-20

Study results available
· View outcomes & findings →

Summary

This study explores the hypothesis that wearable defibrillators can impact mortality by reducing sudden death during the first three months after a heart attack in persons with high risk for life-threatening arrhythmias.

Conditions

  • Myocardial Infarction
  • Ventricular Dysfunction
  • Sudden Death
  • Ventricular Tachycardia
  • Ventricular Fibrillation

Interventions

DEVICE

wearable defibrillator

LifeVest wearable defibrillator

Sponsors & Collaborators

Principal Investigators

  • Jeffrey E Olgin, MD · University of California, San Francisco

  • Byron K Lee, MD · University of California, San Francisco

  • Mark J Pletcher, MD, MPH · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • United States
  • Germany
  • Poland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01446965 on ClinicalTrials.gov